Healthcare Industry Insights

Monday, 17 February 2020

Psoriasis Drugs Market Trends, Analysis, Growth and Outlook Report, 2022

The global Psoriasis Drugs Market size is expected to be valued at USD 21.11 billion by 2022, as per a new report by Grand View Research, Inc., experiencing a CAGR of 9.4% during the forecast period. Rising disease awareness, increasing number of reimbursement strategies for biologics, and advanced diagnostic and technological tools are likely to increase the adoption of psoriasis therapeutics.

Additionally, expanding base of patients suffering from psoriasis is anticipated to fuel growth prospects. The exact causative factors for psoriasis are undetermined; however, certain genetic and environmental factors may trigger the disease onset. Most available treatments aim to decelerate disease progression by stopping hyperproliferation of keratinocyte.

Psoriasis can be classified into five types: plaque, guttate, inverse, pustular, and erythrodermic. The types vary in terms of site of disease and characterization of lesions. Erythrodermic psoriasis is the rarest and plaque psoriasis is the most prevalent type affecting patients all over the world.

Incidence rate of psoriasis has witnessed a gradual rise over the years across various geographical locations. This increase can be attributed to genetic and environmental triggers as well as lifestyle changes. Rise in prevalence rates could also be associated with declining response or developing resistance to therapies for disease control.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/psoriasis-drugs-market

Further key findings from the report suggest:

Tumor Necrosis Factor-inhibitors dominated the market in 2016 owing to its higher usage by healthcare practitioners and easy availability
TNF-inhibitors are likely to lose market shares over the forecast period due to increasing preference for IL-inhibitor therapy to conventional TNF-inhibitors
Interleukin-inhibitors is expected to register a lucrative CAGR of over 21.0% during the forecast period owing to improved safety and efficacy profiles of Interleukin-inhibiting drugs
The U.S is the dominant region in the psoriasis market in terms of revenue in 2016 due to increasing number of patients seeking treatment and presence of well-established healthcare services
Japan is expected to be the fastest growing region during the same period due to growing awareness about the disease among the populace
Some of the key players in this industry are AbbVie Inc.; Amgen Inc.; Johnson & Johnson; Novartis AG; Eli Lilly & Company; AstraZeneca; Celgene Corporation; UCB; and Merck.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Friday, 14 February 2020

Weight Loss Services Market is Projected to Witness 8.4% CAGR till 2025

The global Weight Loss Services Market size is expected to reach USD 21.1 billion by 2025 expanding at a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Rising cases of obesity and resultant health consciousness along with increased per capita healthcare expenditure are the key factors fueling the market growth. Obesity is among the major health concerns that lead to a number of associated diseases or complications, such as diabetes, Cardiovascular Diseases (CVDs), and cancers. For instance, as per WHO, in 2016, more than 1.9 billion adults were overweight, out of which around 650 million people were obese.

Such instances are expected to encourage people to maintain proper health to help lower the risk of such chronic health issues, thereby augmenting market growth. Key companies in the market are focusing on the development of new ways for weight loss, such as Zumba, sports-specific performance training, aquatic exercise classes, and weight loss supplements. For instance, in August 2018, Herbalife International launched Herbalife24 ACHIEVE protein bar, a convenient, energy-providing snack. This product launch may increase the company’s popularity among athletes worldwide. Hence, such initiatives are anticipated to drive the market.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/weight-loss-services-market

Further key findings from the study suggest:

Fitness equipment segment is estimated to register the highest CAGR over the forecast period due to advancements by key companies, in terms of technology and equipment
Consulting services is projected to expand at the highest CAGR due to their cost-effectiveness as compared to other services
APAC is expected to be the fastest-growing regional market in future. Increasing cases of obesity and diabetes due to changing lifestyles are anticipated to drive the region’s growth
Some of the key companies in the global weight loss services market are Atkins Nutritionals, Inc.; Nutrisystem, Inc.; Herbal Life International, Inc.; Apollo Endosurgery, Inc.; Johnson Health Tech; WW International, Inc.; Kellogg Co; Amer Sports; Cynosure, Inc.; and Diet Health, Inc.

Wound Care Market is Projected to Witness 3.9 % CAGR till 2026

The global Wound Care Market size is expected to reach USD 25.1 billion by 2026, according to a new report by Grand View Research, Inc., registering a 3.9% CAGR during the forecast period. Increase in prevalence of chronic diseases globally, rising number of ambulatory surgical centers (ASCs), and growing geriatric population are key factors driving the global market.

ASCs offer a variety of services such as surgical assistance, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, and gastro intestinal (GI) conditions are also performed in ambulatory surgery centers. Earlier, ASCs were only capable of performing GI-related minor surgeries; however, with increase in number of minimally invasive surgical procedures, services offered by ambulatory surgical centers have expanded and grown exponentially.

According to the U.S. Department of Health and Human Services (HHS) data records of 2014, there were 17.2 million hospital visits. These included invasive, therapeutic surgeries, and ambulatory surgeries. Around 9.94 million (57.8%) of these surgeries occurred in hospital-owned ambulatory surgery settings and the remaining 7.26 million surgeries (42.2%) were conducted in hospitals. ASCs are increasing in number and thus offer cost-effective services. In addition, favorable reimbursement coverages are being provided with regard to services provided by ASCs. The chances of contracting post-surgical, hospital-related infections are also reduced. ASCs provide specific instructions to patients regarding post-surgical homecare. Thus, with an increase in the number of ASCs and number of surgical procedures, demand for wound care is expected to increase.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/wound-care-market

Further key findings from the report suggest:

In terms of revenue, the advanced dressing segment held the largest share in 2018 owing to increasing cases of chronic diseases and rising adoption of advanced wound care products across the globe
The home healthcare segment is expected to witness the fastest growth over the forecast period due to increasing geriatric population and rising adoption of negative pressure wound therapy
On the basis of application, the acute segment held the largest wound care market share in 2018 owing to rising number of surgeries and burn cases across the globe
Asia Pacific is expected to witness the fastest growth over the forecast period owing to increasing number of surgeries and rising cases of burns in this region
Prominent key players present in the wound care market include Smith and Nephew; Molnlycke Health Care AB; and Baxter International Inc.

Fiber Optics Market Analysis, Growth Opportunities and Forecast Report, 2025

The global Fiber Optics Market size is expected to reach USD 9.1 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.6% over the forecast period. Rising government funding to develop secure infrastructures is anticipated to drive the adoption.

Rising terrorism is appealing government authorities and defense services of different countries to take initiatives and stringent steps to curb down such occurrences. This has led to the evolution and adoption of technologies such as body cams, wearables, and other responders that keep the security personnel connected, irrespective of user location and user fiber optics for communications. The concept of Internet of Everything (IoE) is attracting security sector owing to increasing awareness regarding effectiveness and efficiency of the technology that aids in curbing national issues, such as riots, massacres, killings, and other criminal offenses. Need for high-speed internet, which is capable of efficiently transmitting the data, is anticipated to grow with increasing demand for IoE.

Growth prospects for fiber optics technology in telecommunications sector appears to be promising due to its growing adoption in communication and data transmission services. Fiber optics enable high-speed data transfer services in both small and long-range communications. It also serves as a medium to cope with increasing bandwidth requirements associated with broadband services, network operators, and broadband connection providers. Rising implementation of fiber optic components in distribution cables, trunk cable forms, high density interconnect cables, and standard patch cords is expected to enhance the demand from telecom sector.

Furthermore, high initial acquisition and installation costs are hindering growth of the fiber optics market. An optical fiber system consists of a variety of components such as optical cables, transmitters, and receivers. Installation of the entire system is a labor-intensive process, especially installation of the network for underground and undersea connections is one of costliest and tedious procedures. Fiber optics, with their advancements, have overtaken the copper-cable transmission. However, installation process to deploy the optical networks, being an extremely high-cost part, is expected to hamper the market growth.

Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/fiber-optics-market

Further key findings from the study suggest:

Governments of developed countries such as U.S., U.K, Germany, China, and Japan are heavily investing in security infrastructures at domestic levels. This is eventually necessitating funding for technologies, majorly across the fiber optics that would enhance the telecommunication sector infrastructure with better security measures. Therefore, the government funding in infrastructure is driving the market
Plastic optical fiber segment is projected to expand at a CAGR of 7.0% over the forecast period. POF differs from its single and multimode counterparts on the basis of the core materials used in POF cable construction. While single and multimode fiber optics have a glass core, POF cables have a polymer core. This offers a dynamic application portfolio, along with cost saving
Market participants are diversifying their product portfolio through their innovative offerings. In March 2018, Corning, Inc. launched a new product Corning TXF Optical Fiber that would enable high data-rate transmission over longer spans and extended reach for improved network flexibility and lower network cost
Corning Incorporated, Optical Cable Corporation (OCC), Sterlite Technologies Limited, OFS Fitel, LLC, Prysmian Group, AFL, Birla Furukawa Fiber Optics Limited, Finolex Cables Limited, and Yangtze Optical Fiber and Cable Co., Ltd. (YOFC) among others are the key players in the fiber optics market.

Wednesday, 12 February 2020

NASH Biomarkers Market Worth $2.09 Billion By 2025

The global Non-Alcoholic Steatohepatitis Biomarkers Market size is expected to reach USD 2.09 billion by 2025, at a CAGR of 30.1% according to a new report by Grand View Research, Inc.

Increasing incidence of chronic liver diseases is expected to propel the demand for NASH biomarkers over the forecast period. The National Health and Nutrition Examination Survey recently found that approximately 30% of Nonalcoholic Fatty Liver Diseases (NAFLD) occurred in the U.S. alone. This disease remains undiagnosed, as a liver can remain fatty without any change in its function. However, it can progress into a serious condition, known as nonalcoholic steatosis that may result in liver failure. NASH is characterized by inflammation and irreversible cell death.

Rising demand for non-invasive diagnostic tools for detection of NASH is another driver of market. Traditionally, liver biopsy is performed to diagnose NAFLD and its degenerative condition, that is, NASH. This technique is expensive and invasive in nature. This disadvantage has led to the development of noninvasive and cost-efficient diagnostic techniques such as biomarker tests. It is observed that many key companies spent significantly on research and development activities to introduce novel biomarker tests. These factors are expected to propel NASH biomarkers market in the coming years.

The drug manufacturers are focusing on tapping unmet medical needs for treatment of NASH to capture additional market share. Strategic collaborations, expansion in developing geographies, and technological advancements are some of the key strategies adopted by existing market players.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/non-alcoholic-steatohepatitis-nash-biomarkers-market

Further Key Findings From the Study Suggest:

Serum biomarkers held majority of the revenue share as of 2016 owing to its high efficacy in NASH diagnosis
Gamma-glutamyl transferase is the serum biomarker that is usually higher in patients with fatty liver diseases, resulting in liver failure
Increasing list of patients awaiting liver transplantation is a major contributing factor for the growing demand of noninvasive biomarker tests over the forecast period
Pharmaceutical and contract research industry dominate the end-use segment owing to ample availability of R&D funding and ongoing research projects for the development NASH drugs
Industry participants are focusing on development of cost-effective solutions, thereby increasing R&D activities for development of novel technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

CNS Therapeutics Market is Projected to Witness 5.9% CAGR till 2025

The global CNS Therapeutic Market is expected to reach USD 128.9 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of mental illnesses and increasing awareness regarding psychiatric disorders are driving market growth. In addition, expanding geriatric population and rising prevalence of lifestyle-associated CNS disorders are increasing global demand for CNS therapeutics.

Mental health segment accounted for the largest market share in 2016. It is expected to retain its dominance over the forecast period owing to developing therapeutic options for mental diseases such as personality disorders and binge eating disorders. This segment is followed by degenerative disorders segment. There is growing awareness regarding neurodegenerative diseases owing to increase in initiatives by government and nongovernment organizations, such as Alzheimer’s and Related Disorders Society of India. These organizations conduct awareness campaigns and conferences, such as Asia Pacific Conference of ADI at New Delhi and Kerala State Initiative on Dementia, which encourage the adoption of treatment for degenerative and mental disorders.

Cancer segment is expected to emerge as the fastest growing segment in the Central Nervous System therapeutics market. High demand for effective treatment and a large number of drugs in later phases of clinical trials are factors expected to propel the growth of the segment.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/central-nervous-system-cns-therapeutic-market

Further Key Findings from the Report Suggest:

Global mental health therapeutics revenue accounted for 48% share in 2016 and is expected to grow at a significant rate from 2016 to 2025
Global demand for the treatment of Parkinson’s and Alzheimer’s diseases is anticipated to witness extensive growth over the next 9 years
The industry in Asia Pacific is expected to report fastest growth over the forecast period owing to various developments across major economies of the region, especially in the mental health sector.
Key players including Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Biogen, Inc.; Johnson & Johnson Services, Inc.; Eli Lilly and Company; and Novartis AG led the global CNS disease treatment market by capturing a majority share

About Grand View Research

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Pharmaceutical Robots Market Trends, Segmentation and Future Scope

The global Pharmaceutical Robots Market size is anticipated to reach USD 430.0 million by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to the flourishing pharmaceutical industry.

The pharmaceutical industry is flourishing due to huge R&D investments by global players. With increasing drug discovery and clinical trials, there is growing demand for robotics. To minimize workload and maintain higher levels of accuracy, automation has become a significant part of pharmaceutical manufacturing. It increases efficiency, prevents performance of repetitive activities, and avoids human error & contamination.

Technological advancement is an important factor driving growth. The use of robots & automated machines in the field of pharmaceuticals is still in its nascent stage and expected to grow in the near future. The automation industry has incorporated a few new techniques such as collaborative robots and laboratory automation.

Pharmaceutical robotic machines also minimize manufacturing costs by reducing labor. These machines are 3 to 4 times faster than humans and have the capacity to work for 24 hours. Reduction in production cost is expected to raise return on investment in the long run, thus driving demand for these products in the future.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/pharmaceutical-robots-market

Further Key Findings From the Study Suggest:

In 2016, traditional robots held the largest share due to their availability in different types, varied applications, and increased awareness
Collaborative robots are expected to witness highest growth over the forecast period owing to their ability to easily integrate with existing manufacturing environments and interact with humans
Picking and packaging segment dominated the market in 2016 since almost all types of robotic machines are primarily used for picking and packaging
Laboratory applications are anticipated to propel significant growth over the forecast period due to increasing laboratory automation and the need to reduce the risk of human contamination
Pharmaceutical companies were the biggest contributors to the growth of the market in 2016 owing to a growing number of new drug development and clinical trials
Asia Pacific dominated the pharmaceutical robots market in 2016 and is also anticipated to be the biggest driver of growth due to high penetration of robotic machines in pharma companies in countries such as China and Japan
Some of the key players include FANUC America Corporation; Kawasaki Heavy Industries, Ltd.; ABB Ltd.; Seiko Epson Corporation; Denso Wave Inc.; Yaskawa Electric Corporation; Universal Robots A/S; and Marchesini Group S.p.A.

About Grand View Research